Need Help?

Double/triple hit lymphoma whole exome and panel sequencing data

Mutational landscape of high-grade B-cell lymphoma with MYC-, BCL2 and/or BCL6 rearrangements characterized by whole-exome sequencing and panel sequencing.

Request Access

This policy is adjusted from the Example DAA template at https://www.ebi.ac.uk/ega/submission/data_access_committee/policy_documentation#DAA, i.e. https://www.ebi.ac.uk/ega/sites/ebi.ac.uk.ega/files/documents/Example_DAA_Oct_2018.doc

DATA ACCESS AGREEMENT These terms and conditions govern access to the managed access datasets (details of which are set out in Appendix I) to which the User Institution has requested access. The User Institution agrees to be bound by these terms and conditions. Definitions Authorised Personnel: The individuals at the User Institution to whom the D/THLData Committee grants access to the Data. This includes the User, the individuals listed in Appendix II and any other individuals for whom the User Institution subsequently requests access to the Data. Details of the initial Authorised Personnel are set out in Appendix II. Data: The managed access datasets to which the User Institution has requested access. Data Producers: D/THLData Committee and the collaborators listed in Appendix I responsible for the development, organisation, and oversight of these Data. The D/THLData Committee (hauke.busch@uni-luebeck.de). External Collaborator: A collaborator of the User, working for an institution other than the User Institution. Project: The project for which the User Institution has requested access to these Data. A description of the Project is set out in Appendix II. Publications: Includes, without limitation, articles published in print journals, electronic journals, reviews, books, posters and other written and verbal presentations of research. Research Participant: An individual whose data form part of these Data. Research Purposes: Shall mean research that is seeking to advance the understanding of genetics and genomics, including the treatment of disorders, and work on statistical methods that may be applied to such research. User: The principal investigator for the Project. User Institution(s): The Institution that has requested access to the Data. XXXXX: Your Institution details here 1. The User Institution agrees to only use these Data for the purpose of the Project (described in Appendix II) and only for Research Purposes. The User Institution further agrees that it will only use these Data for Research Purposes which are within the limitations (if any) set out in Appendix I. 2. The User Institution agrees to preserve, at all times, the confidentiality of these Data. In particular, it undertakes not to use, or attempt to use these Data to compromise or otherwise infringe the confidentiality of information on Research Participants. Without prejudice to the generality of the foregoing, the User Institution agrees to use at least the measures set out in Appendix I to protect these Data. 3. The User Institution agrees to protect the confidentiality of Research Participants in any research papers or publications that they prepare by taking all reasonable care to limit the possibility of identification. 4. The User Institution agrees not to link or combine these Data to other information or archived data available in a way that could re-identify the Research Participants, even if access to that data has been formally granted to the User Institution or is freely available without restriction. 5. The User Institution agrees only to transfer or disclose these Data, in whole or part, or any material derived from these Data, to the Authorised Personnel. Should the User Institution wish to share these Data with an External Collaborator, the External Collaborator must complete a separate application for access to these Data. 6. The User Institution agrees that the Data Producers, and all other parties involved in the creation, funding or protection of these Data: a) make no warranty or representation, express or implied as to the accuracy, quality or comprehensiveness of these Data; b) exclude to the fullest extent permitted by law all liability for actions, claims, proceedings, demands, losses (including but not limited to loss of profit), costs, awards damages and payments made by the Recipient that may arise (whether directly or indirectly) in any way whatsoever from the Recipient’s use of these Data or from the unavailability of, or break in access to, these Data for whatever reason and; c) bear no responsibility for the further analysis or interpretation of these Data. 7. The User Institution agrees to follow the Fort Lauderdale Guidelines (http://www.wellcome.ac.uk/stellent/groups/corporatesite/@policy_communications/documents/web_document/wtd003207.pdf ) and the Toronto Statement (http://www.nature.com/nature/journal/v461/n7261/full/461168a.html). This includes but is not limited to recognising the contribution of the Data Producers and including a proper acknowledgement in all reports or publications resulting from the use of these Data. 8. The User Institution agrees to follow the Publication Policy in Appendix III. This includes respecting the moratorium period for the Data Producers to publish the first peer-reviewed report describing and analysing these Data. 9. The User Institution agrees not to make intellectual property claims on these Data and not to use intellectual property protection in ways that would prevent or block access to, or use of, any element of these Data, or conclusion drawn directly from these Data. 10. The User Institution can elect to perform further research that would add intellectual and resource capital to these data and decide to obtain intellectual property rights on these downstream discoveries. In this case, the User Institution agrees to implement licensing policies that will not obstruct further research and to follow the U.S. National Institutes of Health Best Practices for the Licensing of Genomic Inventions (2005) (https://www.icgc.org/files/daco/NIH_BestPracticesLicensingGenomicInventions_2005_en.pdf ) in conformity with the Organisation for Economic Co-operation and Development Guidelines for the Licensing of the Genetic Inventions (2006) (http://www.oecd.org/science/biotech/36198812.pdf ). 11. The User Institution agrees to destroy/discard the Data held, once it is no longer used for the Project, unless obliged to retain the data for archival purposes in conformity with audit or legal requirements. 12. The User Institution will notify the D/THLData Committee within 30 days of any changes or departures of Authorised Personnel. 13. The User Institution will notify the D/THLData Committee prior to any significant changes to the protocol for the Project. 14. The User Institution will notify the D/THLData Committee as soon as it becomes aware of a breach of the terms or conditions of this agreement. 15. The D/THLData Committee may terminate this agreement by written notice to the User Institution. If this agreement terminates for any reason, the User Institution will be required to destroy any Data held, including copies and backup copies. This clause does not prevent the User Institution from retaining these data for archival purpose in conformity with audit or legal requirements. 16. The User Institution accepts that it may be necessary for the Data Producers to alter the terms of this agreement from time to time. As an example, this may include specific provisions relating to the Data required by Data Producers other than the D/THLData Committee. In the event that changes are required, the Data Producers or their appointed agent will contact the User Institution to inform it of the changes and the User Institution may elect to accept the changes or terminate the agreement. 17. If requested, the User Institution will allow data security and management documentation to be inspected to verify that it is complying with the terms of this agreement. 18. The User Institution agrees to distribute a copy of these terms to the Authorised Personnel. The User Institution will procure that the Authorised Personnel comply with the terms of this agreement. 19. This agreement (and any dispute, controversy, proceedings or claim of whatever nature arising out of this agreement or its formation) shall be construed, interpreted and governed by the laws of Germany and shall be subject to the exclusive jurisdiction of German courts. Agreed for User Institution Signature: Name: Title: Date: Principal Investigator I confirm that I have read and understood this Agreement. Signature: Name: Title: Date: Agreed for XXXXX Signature: Name: Title: Date: APPENDIX I – DATASET DETAILS APPENDIX II ––PROJECT DETAILS APPENDIX III –– PUBLICATION POLICY APPENDIX I – DATASET DETAILS (to be completed by the data producer before passing to applicant) Dataset reference (EGA Study ID and Dataset Details) Name of project that created the dataset Names of other data producers/collaborators Axel Künstner (Axel.Kuenstner@uni-luebeck.de) Niklas Gebauer (Niklas.Gebauer@uksh.de) * Hauke Busch (Hauke.Busch@uni-luebeck.de) * Constitute the Data Access Committee Specific limitations on areas of research Minimum protection measures required File access: Data can be held in unencrypted files on an institutional compute system, with Unix user group read/write access for one or more appropriate groups but not Unix world read/write access behind a secure firewall. Laptops holding these data should have password protected logins and screenlocks (set to lock after 5 min of inactivity). If held on USB keys or other portable hard drives, the data must be encrypted. APPENDIX II – PROJECT DETAILS (to be completed by the Requestor) Details of dataset requested i.e., EGA Study and Dataset Accession Number Brief abstract of the Project in which the Data will be used (500 words max) All Individuals who the User Institution to be named as registered users Name of Registered User Email Job Title Supervisor* All Individuals that should have an account created at the EGA Name of Registered User Email Job Title APPENDIX III – PUBLICATION POLICY The D/THLdata producers and collaborators named in Appendix I intend to publish the results of their analysis of this dataset in a peer-reviewed journal and do not consider its deposition into public databases to be the equivalent of such publications. The data producers anticipate that the dataset could be useful to other qualified researchers for a variety of purposes. However, some areas of work are subject to a publication moratorium. The publication moratorium covers any publications (including oral communications) that describe the use of the dataset. For research papers, submission for publication should not occur until peer-reviewed journal publication of the EGA study unless the D/THLData Committee has provided written consent to earlier submission. In any publications based on these data, please describe how the data can be accessed, including the name of the hosting database (e.g., The European Genome-phenome Archive at the European Bioinformatics Institute) and its accession numbers (e.g., EGAS00000000029), and acknowledge its use in a form agreed by the User Institution with the D/THLData Committee.

Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.

Study ID Study Title Study Type
EGAS00001005420 Other

This table displays only public information pertaining to the files in the dataset. If you wish to access this dataset, please submit a request. If you already have access to these data files, please consult the download documentation.

ID File Type Size Located in
EGAF00005329866 bam 59.8 GB
EGAF00005329867 bam 10.1 GB
EGAF00005329868 bam 12.7 GB
EGAF00005329869 bam 12.0 GB
EGAF00005329870 bam 25.3 GB
EGAF00005329871 bam 19.2 GB
EGAF00005329872 bam 16.2 GB
EGAF00005329873 bam 27.7 GB
EGAF00005329874 bam 24.5 GB
EGAF00005329875 bam 13.0 GB
EGAF00005329876 bam 13.9 GB
EGAF00005329877 bam 15.2 GB
EGAF00005329878 bam 16.7 GB
EGAF00005329879 bam 23.9 GB
EGAF00005329880 bam 28.3 GB
EGAF00005329881 bam 14.0 GB
EGAF00005329882 bam 16.8 GB
EGAF00005329883 bam 542.3 MB
EGAF00005329884 bam 406.5 MB
EGAF00005329885 bam 16.5 GB
EGAF00005329886 bam 15.2 GB
EGAF00005329887 bam 15.3 GB
EGAF00005329888 bam 12.6 GB
EGAF00005329889 bam 27.6 GB
EGAF00005329890 bam 12.2 GB
EGAF00005329891 bam 39.3 GB
EGAF00005329892 bam 13.0 GB
EGAF00005329893 bam 32.6 GB
EGAF00005329894 bam 24.2 GB
EGAF00005329895 bam 478.1 MB
EGAF00005329896 bam 175.2 MB
EGAF00005329897 bam 529.3 MB
EGAF00005329898 bam 33.0 GB
EGAF00005329899 bam 19.8 GB
EGAF00005329900 bam 646.3 MB
EGAF00005329901 bam 12.6 GB
EGAF00005329902 bam 408.6 MB
EGAF00005329903 bam 25.5 GB
EGAF00005329904 bam 368.8 MB
EGAF00005329905 bam 755.3 MB
EGAF00005329906 bam 24.0 GB
EGAF00005329907 bam 28.1 GB
EGAF00005329908 bam 12.9 GB
EGAF00005329909 bam 266.5 MB
EGAF00005329910 bam 13.7 GB
EGAF00005329911 bam 12.5 GB
EGAF00005329912 bam 734.4 MB
EGAF00005329913 bam 326.0 MB
EGAF00005329914 bam 400.1 MB
EGAF00005329915 bam 14.9 GB
EGAF00005329916 bam 277.4 MB
EGAF00005329917 bam 22.9 GB
EGAF00005329918 bam 22.7 GB
EGAF00005329919 bam 22.5 GB
EGAF00005329920 bam 15.3 GB
EGAF00005329921 bam 1.1 GB
EGAF00005329922 bam 17.8 GB
EGAF00005329923 bam 705.1 MB
EGAF00005329924 bam 19.5 GB
EGAF00005329925 bam 445.0 MB
EGAF00005329926 bam 9.7 GB
EGAF00005329927 bam 18.2 GB
EGAF00005329928 bam 17.8 GB
EGAF00005329929 bam 12.5 GB
EGAF00005329930 bam 14.4 GB
EGAF00005329931 bam 16.6 GB
EGAF00005329932 bam 689.5 MB
EGAF00005329933 bam 352.0 MB
EGAF00005329934 bam 14.8 GB
EGAF00005329935 bam 10.3 GB
EGAF00005329936 bam 41.1 GB
EGAF00005329937 bam 16.4 GB
EGAF00005329938 bam 12.8 GB
EGAF00005329939 bai 2.2 MB
EGAF00005329940 bai 7.5 MB
EGAF00005329941 bai 6.7 MB
EGAF00005329942 bai 6.7 MB
EGAF00005329943 bai 7.2 MB
EGAF00005329944 bai 2.0 MB
EGAF00005329945 bai 6.4 MB
EGAF00005329946 bai 6.6 MB
EGAF00005329947 bai 6.4 MB
EGAF00005329948 bai 6.4 MB
EGAF00005329949 bai 6.4 MB
EGAF00005329950 bai 1.8 MB
EGAF00005329951 bai 6.9 MB
EGAF00005329952 bai 1.7 MB
EGAF00005329953 bai 6.9 MB
EGAF00005329954 bai 6.7 MB
EGAF00005329955 bai 6.8 MB
EGAF00005329956 bai 6.8 MB
EGAF00005329957 bai 1.9 MB
EGAF00005329958 bai 6.8 MB
EGAF00005329959 bai 6.4 MB
EGAF00005329960 bai 1.8 MB
EGAF00005329961 bai 7.3 MB
EGAF00005329962 bai 2.1 MB
EGAF00005329963 bai 6.6 MB
EGAF00005329964 bai 1.9 MB
EGAF00005329965 bai 6.5 MB
EGAF00005329966 bai 6.7 MB
EGAF00005329967 bai 6.6 MB
EGAF00005329968 bai 1.9 MB
EGAF00005329969 bai 2.1 MB
EGAF00005329970 bai 6.5 MB
EGAF00005329971 bai 1.7 MB
EGAF00005329972 bai 6.7 MB
EGAF00005329973 bai 6.3 MB
EGAF00005329974 bai 6.7 MB
EGAF00005329975 bai 6.7 MB
EGAF00005329976 bai 6.5 MB
EGAF00005329977 bai 7.1 MB
EGAF00005329978 bai 7.5 MB
EGAF00005329979 bai 6.7 MB
EGAF00005329980 bai 6.7 MB
EGAF00005329981 bai 6.4 MB
EGAF00005329982 bai 7.1 MB
EGAF00005329983 bai 6.4 MB
EGAF00005329984 bai 7.4 MB
EGAF00005329985 bai 1.9 MB
EGAF00005329986 bai 6.6 MB
EGAF00005329987 bai 2.1 MB
EGAF00005329988 bai 6.4 MB
EGAF00005329989 bai 3.8 MB
EGAF00005329990 bai 6.4 MB
EGAF00005329991 bai 1.8 MB
EGAF00005329992 bai 7.0 MB
EGAF00005329993 bai 6.4 MB
EGAF00005329994 bai 6.8 MB
EGAF00005329995 bai 6.5 MB
EGAF00005329996 bai 1.7 MB
EGAF00005329997 bai 7.3 MB
EGAF00005329998 bai 6.7 MB
EGAF00005329999 bai 6.6 MB
EGAF00005330000 bai 6.5 MB
EGAF00005330001 bai 7.0 MB
EGAF00005330002 bai 2.0 MB
EGAF00005330003 bai 2.2 MB
EGAF00005330004 bai 1.7 MB
EGAF00005330005 bai 6.5 MB
EGAF00005330006 bai 7.3 MB
EGAF00005330007 bai 6.5 MB
EGAF00005330008 bai 7.3 MB
EGAF00005330009 bai 6.6 MB
EGAF00005330010 bai 6.7 MB
EGAF00005330011 bai 6.9 MB
146 Files (1.1 TB)